PAA 2.86% 18.0¢ pharmaust limited

Ann: PharmAust MND Trial Interim Analysis PK Outcomes, page-50

  1. 2,643 Posts.
    lightbulb Created with Sketch. 1449
    Correct. Yes it is a necessary step but the market doesnt care. Whats the point of a safe substance if it doesnt do anything. It could be sherbert at this stage for all the market cares.

    This is another boy who cried wolf announcement in eyes of market.

    Now before all the Roger defenders attack, I actually think this announcement is very important In the overall picture.

    But this is not the progress the market wants. Where are the bloody results that tell us whether this drug will ever be commercially viable for any indication. At least commit to when you will have them.

    Roger as far as i see has around 16 days to come through with goods on canine and MND. If more timelines slips occur I hope people vote appropriately in the upcoming meeting.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.0¢
Change
0.005(2.86%)
Mkt cap ! $87.51M
Open High Low Value Volume
17.5¢ 18.3¢ 17.5¢ $205.5K 1.150M

Buyers (Bids)

No. Vol. Price($)
2 55777 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 56756 2
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.